FLGT
Fulgent Genetics, Inc.
NASDAQ · Healthcare · Medical - Diagnostics & Research · US
$19.73
+0.41%Forward multiples
Based on analyst estimates
- P/E forward
- —
- P/E 2026E
- —
- P/E 2027E
- —
- P/E 2028E
- —
- P/S forward
- 1.50x
Trailing multiples
Trailing twelve months
- P/E TTM
- —
- PEG TTM
- —
- Price / book
- 0.54x
- Price / sales
- 1.68x
- Price / cash flow
- -6.49x
Enterprise value
- Enterprise value
- $289.6M
- EV / sales
- 0.89x
- EV / EBITDA
- -4.45x
- EV / EBIT
- -2.41x
- Market cap
- $542.9M
Trailing, forward and enterprise-value multiples for the requested listing · Data as of Jun 1, 2026